Properties and stability of a liquid crystal form of cyclosporine - The first reported naturally occurring peptide that exists as a thermotropic liquid crystal

Journal of Pharmaceutical Sciences

Volumn 92, Issue 9, 2003, Pages 1821-1831

  Lechuga Ballesteros, David ^a   Abdul Fattah, Ahmad ^a,b   Stevenson, Cynthia L ^a   Bennett, David B ^a  

^a NEKTAR THERAPEUTICS   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Enthalpic relaxation; Liquid crystal; Solid state characterization; Stability; Thermotropic

Indexed keywords

CYCLOSPORIN;

ARTICLE; BIREFRINGENCE; CRYSTALLIZATION; DIELECTRIC CONSTANT; DIFFERENTIAL SCANNING CALORIMETRY; DRUG STABILITY; FREEZING; LIQUID; LIQUID CRYSTAL; MICROSCOPIC ANATOMY; NONHUMAN; PEPTIDE ANALYSIS; PHASE TRANSITION; POLARIZATION MICROSCOPE; REACTION ANALYSIS; ROOM TEMPERATURE; SOLID; SOLVENT EFFECT; SPRAY DRYING; STRUCTURE ANALYSIS; TEMPERATURE DEPENDENCE; TEMPERATURE MEASUREMENT; THERMOTROPIC LIQUID CRYSTAL; X RAY CRYSTALLOGRAPHY; X RAY POWDER DIFFRACTION;

EID: 0041837235     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.10444     Document Type: Article

References (21)

1. Keenan RJ, Iacono A, Dauber JH, Zeevi A, Adriana SA, Ohori NP, Burchart GJ, Dawai A, Smaldone GC, Griffith BP. 1997. Treatment of refractory acute allograft rejection with aerosolized cyclosporine in lung transplant recipients. J Thorac Cardiovasc Surg 113:335-341.
2. Smaldone GC. 1998. Treatment of transplant rejection by aerosolized cyclosporine. In: Dalby RN, Byron P, Farr SJ, editors. Respiratory drug delivery VI. Buffalo, NY: Interpharm Press, Inc., pp 103-111.
3. Morley J, Rummelt A, List M. 1992. Ciclosporin form for pulmonary administration. Eur Pat EP 0504760.
4. Lechuga-Ballesteros D, Bennett D, Cabot K, Farinas K, Gong D, Hastedt J, Ramanathan S, Tan T, Venthoye G, Williams L, Wang M. 2000. Aerosol drug development of a spray dried liquid crystalline formulation of cyclosporine. In: Dalby RN, Byron P, Farr SJ, Peart J, editors. Respiratory drug delivery VII. Raleigh, NC: Serentec Press, Inc., pp 247-256.
5. Bennett D, Cabot K, Foster L, Lechuga-Ballesteros D, Patton J, Tan T. 1999. Liquid crystal forms of cyclosporin. Int Applic Number WO 99/42124.
6. Brown GH, Crooker PP. 1983. Liquid crystals a colorful state of matter. Chem Eng News 61(5):24-38.
7. Chandrasekhar S. 1992. Liquid crystals. Cambridge: Cambridge University Press.
8. Redas T, Muller-Goymann CC. 1994. Melting behavior and thermotropic mesomorphism of fenoprofen salts. Eur J Biopharm 40:277-282.
9. Loosli HR, Kessler H, Oschkinat H, Weber HP, Petcher T, Wider A. 1985. The conformation of cyclosporin A in the crystal and in solution. Helvet Chim Acta 68:682-703.
10. Giron D, List M, Richter F, Ulke Y, Weber HP. 1989. New cyclosporin crystal form, process for its production, pharmaceutical compositions containing it and its use. Sandoz Pat. DE 3843054 A1.
11. Knott RB, Schefer J, Schoenborn BP. 1990. Neutron structure of the immunosuppressant cyclosporin A. Acta Crystallogr C46:1528-1533.
12. Gallot B, Fafiotte M, Fissi A, Pieroni O. 1997. Poly(L-lysine) containing azobenzene units in the side chains: Influence of the degree of substitution on liquid crystalline structure and thermotropic behavior. Liquid Crystals 23:137-146.
13. Okoshi K, Sano N, Suzaki G, Tokita M, Watanabe J, Magoshi J. 2002. Smectic liquid crystal observed in thermotropic system of rigid-rod poly(GAMMA-octadecyl L-glutamate). Jpn J Appl Phys Part 2 41: L720-L722.
14. McMillan RA, Wright ER, Conticello VP. 2001. Elastin-mimetic protein polymers: Biologically derived smart materials. Smart structures and materials 2001: Industrial and commercial applications of smart structures technologies, New Port, CA. SPIE International Society for Optical Engineering, pp 439-454.
15. Duddu SP, Sokoloski TD. 1995. Dielectric analysis in the characterization of amorphous pharmaceutical solids. 1. Molecular mobility in poly(vinylpyrrolidone)-water systems in the glassy state. J Pharm Sci 84:773-776.
16. Oliyai R, Stella VJ. 1992. Kinetics and mechanism of isomerization of cyclosporin A. Pharmaceut Res 9:617-622.
17. Knot RB, Schefer J, Schoenborn BP. 1990. Neutron structure of the immunosuppressant cyclosporin A. Acta Crystallogr C46:1528-1533.
18. Johari GP, Goodby JW. 1982. Dielectric relaxation in a supercooled liquid and glassy smectic phase. J Chem Phys 77:5165-5172.
19. Ko SY, Dalvit C. 1992. Conformation of cyclosporin A in polar solvents. Int J Peptide Protein Res 40: 380-382.
20. Stevenson CL, Tan MM. 2001. Active "aqueous" conformation of cyclosporin A, by FTIR, from organic co-solvent solutions. AAPS Pharm Sci 3(3), Abstract.
21. Yonemochi E, Inoue Y, Buckton G, Moffat A, Oguchi T, Yamamoto K. 1999. Differences in crystallization behavior between quenched and ground amorphous ursodeoxycholic acid. Pharm Res 16: 835-840.